Endpoints News 9 ene 2026 Krystal Biotech says it can deliver native protein to cystic fibrosis patients
Endpoints News 9 ene 2026 Gene editing pioneers launch first startup focused on custom CRISPR therapies
Endpoints News 9 ene 2026 Aktis lands biotech's first IPO of 2026, raising $318M for radiopharmaceuticals